2027 Request for Proposals - ADDF-Harrington Scholar Program
The ADDF-Harrington Scholar Program funds and supports innovative academic drug discovery projects targeting novel mechanisms for Alzheimer’s and related dementias, advancing them toward new therapies.
Funder: Alzheimer's Drug Discovery Foundation
Due Dates: August 17, 2026 (Full proposal deadline, 5:00 PM ET)
Funding Amounts: Up to $600,000 total over 2 years; milestone-driven payments.
Summary: Funds innovative academic drug discovery projects for Alzheimer’s and related dementias, providing both financial support and expert industry guidance.
Description
The ADDF-Harrington Scholar Program is a collaborative initiative between the Alzheimer’s Drug Discovery Foundation and the Harrington Discovery Institute. Its goal is to advance promising academic discoveries into medicines for Alzheimer’s disease and related dementias. The program offers milestone-driven funding (up to $600,000 over two years) and tailored project support from pharmaceutical industry veterans. Projects must focus on novel or emerging therapeutic targets—such as proteostasis, senescence, or other innovative mechanisms—rather than established anti-amyloid or cholinesterase approaches. Awardees benefit from expert guidance, networking opportunities, and participation in a scientific community, including an annual symposium.
